A detailed history of Cibc Bancorp Usa Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 2,987,072 shares of DXCM stock, worth $173 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
2,987,072
Holding current value
$173 Million
% of portfolio
0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 21, 2025

SELL
$66.46 - $89.53 $194 Million - $261 Million
-2,918,612 Reduced 97.71%
68,460 $4.61 Million
Q3 2025

Nov 12, 2025

BUY
$66.46 - $89.53 $199 Million - $267 Million
2,987,072 New
2,987,072 $201 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Cibc Bancorp Usa Inc. Portfolio

Follow Cibc Bancorp Usa Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Bancorp Usa Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc Bancorp Usa Inc. with notifications on news.